Mark Earl Hensley Exercises Options at Heron Therapeutics Inc DE (HRTX) — SEC Form 4, Nov 03, 2026
SEC Form 4 · No Market Transaction
Option Exercise
Derivative exercise — no open market transaction.
Equity Position
183K sh
174,250 → 182,671
Equity Change
+4.8%
shares held after vs before
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Mark Earl Hensley CIK 0002065816 |
COO
|
Mark Earl Hensley at Heron Therapeutics Inc DE
Full insider history
Bought (12 mo)
—
Sold (12 mo)
—
More from this insider at Heron Therapeutics Inc DE
| 2026-08-10 | Exercise | — | View |
| 2026-08-03 | Exercise | — | View |
| 2026-05-07 | Exercise | — | View |
| 2026-05-04 | Exercise | — | View |
| 2026-02-03 | Award | — | View |
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common StockF1 | 2026-10-30 | M - Exercise | 11,770 A | — | 182,671 | Direct | |
| Common Stock | 2026-10-30 | F - Tax Payment | 3,349 D | $0.28 | -$938 | 179,322 | Direct |
Derivative Securities Transactions
Footnotes (2)
- F1
- Each restricted stock unit represents a contingent right to receive one share of common stock. Show more
- F2
- On January 30, 2026 (the "Date of Grant"), the Reporting Person was granted 188,315 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant. Show more
Related filings at Heron Therapeutics Inc DE
Institutional Holders
13F holders · Jun 30, 2026
164
institutional managers reporting a position
Largest by reported value
- Rubric Capital Management Lp $12.8M
- Clearline Capital Lp $4.86M
- Black Rock, Inc. $4.5M
5%+ Holders · 13D/G
2 filers
-
Clearline Capital Lp 6.7%
Other insiders at Heron Therapeutics Inc DE
GET /v1/forms/4/0001193125-26-444831
API docs
View Original SEC Filing